Recombinant Human CD58 protein (rFc Tag) (HPLC verified)
Species
Human
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg4236
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human CD58 protein Phe29-Arg215 (Accession# Q9BRW0) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 965 |
Accession | Q9BRW0 |
PredictedSize | 47.7 kDa |
SDS-PAGE | 55-80 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
CD58, also known as LFA-3 (Lymphocyte Function-Associated Antigen 3), is a cell surface glycoprotein that plays a crucial role in immune cell interactions. It is a member of the immunoglobulin superfamily and acts as a ligand for CD2, primarily expressed in T and NK cells. The CD2-CD58 interaction is an important component of the immunological synapse that induces activation and proliferation of T/NK cells, triggering a series of intracellular signaling pathways. CD58 has been implicated in various diseases, particularly in the context of cancer. It acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
References:
1.Wang C. et al. (2023). J Transl Med. 21(1):539. 2.Zhang Y. et al. (2021). Front Immunol. 12:705260. 3.Wu B. et al. (2024). Commun Biol. 7(1):1025.